ANDO GORAN 4
4 · EyePoint Pharmaceuticals, Inc. · Filed Jan 9, 2024
Insider Transaction Report
Form 4
ANDO GORAN
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-01-05+23,598→ 23,598 totalExercise: $20.40From: 2025-01-05Exp: 2034-01-04→ Common Stock (23,598 underlying)